68-3

45/130

E: Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci, 1996; 37: 290- 299.28) Gubhaju L, Sutherland MR, Yoder BA, Zulli A, Bertram JF, Black MJ: Is nephrogenesis affected by preterm birth? Studies in a non-human primate model. Am J Physiol Renal Physiol, 2009; 297: F1668-F1677.29) Guo JD, Li L, Shi YM, Wang HD, Hou SX: Hydrogen water consumption prevents osteopenia in ovariecto-mized rats. Br J Pharmacol, 2013; 168: 1412-1420.30) Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S: Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Cancer Chemother Pharmacol. 2009; 64: 753-761.31) Cardinal JS, Zhan J, Wang Y, et al: Oral hydrogen water prevents chronic allograft nephropathy in rats. Kidney Int, 2010 Jan; 77: 101-10932) Liu A, Dardik A, Ballermann BJ: Neutralizing TGF-b1 antibody infusion in neonatal rat delays in vivo glomer-ular capillary formation. Kidney Int, 1999; 56: 1334-1348.33) Mehaffey E, Majid DSA: Tumor necrosis factor-α, kidney function, and hypertension. Am J Physiol Renal Physiol, 2017; 313: F1005-F1008.34) Xu C, Chang A, Hack BK, Eadon MT, Alpher SL, Cunningham PN: TNF-mediated damage to glomer-ular endothelium is an important determinant of acute kidney injury in sepsis. Kidney Int, 2014; 85: 72-81.35) Ohta, S. Molecular hydrogen as a preventive and ther-apeutic medical gas: initiation, development and poten-tial of hydrogen medicine. Pharmacol.Ther, 2014; 144: 1-11.36) Ono H, Nishijima Y, Adachi N, et al: A basic study on molecular hydrogen (H2) inhalation in acute cerebral ischemia patients for safety check with physiological parameters and measurement of blood H2 level. Med. Gas Res, 2012; 2: 21.241